MS study probes hidden nerve damage to improve daily life

NCT ID NCT05748015

Recruiting now Knowledge-focused Sponsor: Istituti Clinici Scientifici Maugeri SpA Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how multiple sclerosis affects the autonomic nervous system, which controls automatic body functions like heart rate and sweating. Researchers will use skin biopsies and heart tests to measure nerve damage in 60 people with relapsing-remitting or primary progressive MS. The goal is to better understand symptoms like dizziness and temperature issues, and to see if different MS types have different patterns of nerve involvement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better management of symptoms like dizziness and temperature control in multiple sclerosis patients.
What could go wrong: This is an early observational study with only 60 participants, so findings may not apply to all MS patients and may not lead to new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis primary progressive multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Locations

Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II
RECRUITING

Naples, 80131, Italy
ICS Maugeri - IRCCS of Telese Terme
RECRUITING

Telese Terme, Benevento, 82037, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.